.jpg)
November 14, 2024 – BackStop Neural, a pioneer in the development of the world’s first thin film-based spinal cord stimulator (SCS) paddle lead, is proud to announce it has been awarded the prestigious Gold Electrode for “Most Promising Startup” at the 2024 Neurotech Leaders Forum. The event, held both in person and virtually, brought together key executives, entrepreneurs, investors, and researchers to explore innovation and investment in neurotechnology.
The Neurotech Leaders Forum, hosted by Neurotech Reports, serves as a focal point for thought leadership in the neurotechnology space, with presentations from experts across neuromodulation, neuroprosthetics, neurodiagnostics, and neurorehabilitation. Attendees gained insights into emerging applications like deep-brain stimulation, brain-computer interfaces, stroke rehabilitation, and more. BackStop Neural’s success was recognized for its potential impact on the SCS industry and its progress in developing clinically effective and commercially viable neuromodulation solutions.
BackStop Neural Chief Product Officer Kial Gramley presented on the company's cutting-edge work in implantable spinal cord stimulators aimed at chronic pain relief and motor recovery. “We are deeply honored to be recognized as the Most Promising Startup at the Neurotech Leaders Forum. This award is a testament to our team's dedication to expanding the eligible patient population for SCS through leads that are ten times thinner than current products. It is inspiring to work alongside such a talented group of individuals as we continue to innovate to make a positive impact on the lives of those with chronic pain,” said Gramley.
James Cavuoto, Editor of Neurotech Reports and host of the Neurotech Leaders Forum, commented on BackStop Neural’s award: “BackStop Neural is addressing a critical need in neuromodulation, and their innovative approach to spinal cord stimulation technology has impressed our editorial team. We are pleased to award them the Gold Electrode for Most Promising Startup and look forward to seeing the company’s future contributions to the neurotechnology industry.”
BackStop Neural’s Gold Electrode win is part of a growing list of achievements for the company, including recent product development milestones, an SBIR award from the National Institutes of Health, and successful engagement with investors and partners. With a mission to relieve pain and restore movement through the next generation of implantable devices, BackStop Neural is well-positioned to lead in the advancement of neurotechnology solutions.
For more information about BackStop Neural and its latest developments, please visit www.backstopneural.com .
About BackStop Neural
BackStop Neural is a pioneering medical device company that specializes in developing advanced spinal cord stimulation solutions for individuals suffering from chronic pain and paralysis. Through proprietary materials and neurostimulation technology, the company strives to provide patients with a renewed sense of hope and freedom from debilitating conditions. With a team of dedicated experts and a patient-centered approach, BackStop Neural aims to transform the landscape of neurology and elevate the standard of patient care.
For media inquiries, please contact:
Kial Gramley, Chief Product Officer
(956) 219-6752
Comentários